AIkido Pharma, Inc.(NASDAQ : AIKI)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||0.26%||7.68||0.7%||$536.86m|
|GILD||Gilead Sciences, Inc.||-0.55%||68.53||1.0%||$504.56m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.11%||516.62||2.7%||$432.65m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.09%||173.49||2.0%||$412.31m|
|VRTX||Vertex Pharmaceuticals, Inc.||1.28%||217.09||1.9%||$311.54m|
|CRSP||CRISPR Therapeutics AG||5.58%||106.64||0.6%||$171.41m|
|BNGO||Bionano Genomics, Inc.||22.45%||5.40||0.0%||$162.77m|
AIkido Pharma, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.